Colitis and colon cancer in WASP-deficient mice require helicobacter species
- PMID: 23820270
- PMCID: PMC4082694
- DOI: 10.1097/MIB.0b013e318295fd8f
Colitis and colon cancer in WASP-deficient mice require helicobacter species
Abstract
Background: Wiskott-Aldrich syndrome protein-deficient patients and mice are immunodeficient and can develop inflammatory bowel disease. The intestinal microbiome is critical to the development of colitis in most animal models, in which Helicobacter spp. have been implicated in disease pathogenesis. We sought to determine the role of Helicobacter spp. in colitis development in Wiskott-Aldrich syndrome protein-deficient (WKO) mice.
Methods: Feces from WKO mice raised under specific pathogen-free conditions were evaluated for the presence of Helicobacter spp., after which a subset of mice were rederived in Helicobacter spp.-free conditions. Helicobacter spp.-free WKO animals were subsequently infected with Helicobacter bilis.
Results: Helicobacter spp. were detected in feces from WKO mice. After rederivation in Helicobacter spp.-free conditions, WKO mice did not develop spontaneous colitis but were susceptible to radiation-induced colitis. Moreover, a T-cell transfer model of colitis dependent on Wiskott-Aldrich syndrome protein-deficient innate immune cells also required Helicobacter spp. colonization. Helicobacter bilis infection of rederived WKO mice led to typhlitis and colitis. Most notably, several H. bilis-infected animals developed dysplasia with 10% demonstrating colon carcinoma, which was not observed in uninfected controls.
Conclusions: Spontaneous and T-cell transfer, but not radiation-induced, colitis in WKO mice is dependent on the presence of Helicobacter spp. Furthermore, H. bilis infection is sufficient to induce typhlocolitis and colon cancer in Helicobacter spp.-free WKO mice. This animal model of a human immunodeficiency with chronic colitis and increased risk of colon cancer parallels what is seen in human colitis and implicates specific microbial constituents in promoting immune dysregulation in the intestinal mucosa.
Conflict of interest statement
The authors have no financial conflict of interest to declare.
Figures





References
-
- Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635–644. - PubMed
-
- Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622–e627. - PubMed
-
- Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9:81–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30ES02109/ES/NIEHS NIH HHS/United States
- R01 OD011141/OD/NIH HHS/United States
- P01CA026731/CA/NCI NIH HHS/United States
- R01 AI050950/AI/NIAID NIH HHS/United States
- K08DK083430/DK/NIDDK NIH HHS/United States
- P30 DK34854/DK/NIDDK NIH HHS/United States
- P01 CA026731/CA/NCI NIH HHS/United States
- R01 CA067529/CA/NCI NIH HHS/United States
- P01 HL059561/HL/NHLBI NIH HHS/United States
- K08 DK083430/DK/NIDDK NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- R01AI50950/AI/NIAID NIH HHS/United States
- P30 DK034854/DK/NIDDK NIH HHS/United States
- P30 ES002109/ES/NIEHS NIH HHS/United States
- R01CA067529/CA/NCI NIH HHS/United States
- R01OD011141/OD/NIH HHS/United States
LinkOut - more resources
Medical